Showing 1 posts of 1 posts found.
Cindy Whitehead has left Sprout Pharmaceuticals, just four months after guiding the female libido drug Addyi to FDA approval and overseeing …
NEC joins €6.5m European project using AI for pandemic vaccine design
The evidence bar impacting UK medical cannabis access
Survey highlights mental health burden among rare disease patients and families
Addressing the rheumatic disease diagnostic gap in primary care
How chronic disease creates opportunity on diagnostic and therapeutic pipelines